Puradigm, a leading manufacturer of proactive air and surface purification technologies, that have been proven to inactivate SARS-CoV-2, the virus responsible for COVID-19 and the Delta Variant, released the results of a study published by researchers at the Insight Research Institute and Central Michigan University the Infectious Disease Report that tested the use of photocatalytic reactors to clean and disinfect contaminated surfaces.
Surface decontamination is a basic approach to reducing the spread of infections and there is a pressing need for efficient cleaning and decontamination technologies given the burden of C. difficile and MRSA infections within hospitals as well as the emergence of highly transmissible diseases such as COVID-19.
Puradigm photocatalytic reactors were tested in both hospital room and biosafety cabinet environments. Data showed that the growth of viral infections, S. aureus and C. difficile, were reduced by over 99% each after 24 and 48 hours respectively, compared to control rooms. RNA viruses (DENV2 used as an experimental model) were reduced by 98.5% after 24 hours.
“As people have begun traveling again, as well as with the upcoming holiday season, this technology is key in keeping indoor spaces such as hotels and restaurants purified,” said Jim Gabriel, CEO of Puradigm.
View full report: